Ameriprise’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-168,646
| Closed | -$3.03M | – | 3836 |
|
|
2020
Q2 | $3.03M | Buy |
168,646
+157,714
| +1,443% | +$2.84M | ﹤0.01% | 2391 |
|
|
2020
Q1 | $78K | Sell |
10,932
-13,949
| -56% | -$99.5K | ﹤0.01% | 3557 |
|
|
2019
Q4 | $593K | Sell |
24,881
-5,085
| -17% | -$121K | ﹤0.01% | 3273 |
|
|
2019
Q3 | $804K | Sell |
29,966
-23,226
| -44% | -$623K | ﹤0.01% | 3104 |
|
|
2019
Q2 | $1.44M | Sell |
53,192
-25,115
| -32% | -$680K | ﹤0.01% | 2911 |
|
|
2019
Q1 | $2.72M | Buy |
78,307
+45,509
| +139% | +$1.58M | ﹤0.01% | 2594 |
|
|
2018
Q4 | $640K | Buy |
+32,798
| New | +$640K | ﹤0.01% | 3107 |
|
|
2018
Q3 | – | Sell |
-5,783
| Closed | -$218K | – | 3799 |
|
|
2018
Q2 | $218K | Buy |
+5,783
| New | +$218K | ﹤0.01% | 3452 |
|
|
2018
Q1 | – | Sell |
-32,000
| Closed | -$1.56M | – | 3722 |
|
|
2017
Q4 | $1.56M | Buy |
32,000
+528
| +2% | +$25.7K | ﹤0.01% | 2775 |
|
|
2017
Q3 | $1.7M | Buy |
31,472
+98
| +0.3% | +$5.29K | ﹤0.01% | 2693 |
|
|
2017
Q2 | $1.76M | Buy |
+31,374
| New | +$1.76M | ﹤0.01% | 2668 |
|
|
2016
Q1 | – | Sell |
-87,693
| Closed | -$4.51M | – | 3894 |
|
|
2015
Q4 | $4.51M | Buy |
87,693
+12,246
| +16% | +$630K | ﹤0.01% | 2082 |
|
|
2015
Q3 | $3.22M | Buy |
75,447
+33,464
| +80% | +$1.43M | ﹤0.01% | 2304 |
|
|
2015
Q2 | $1.91M | Buy |
+41,983
| New | +$1.91M | ﹤0.01% | 2767 |
|
|
2013
Q4 | – | Sell |
-604
| Closed | -$16K | – | 5506 |
|
|
2013
Q3 | $16K | Hold |
604
| – | – | ﹤0.01% | 4577 |
|
|
2013
Q2 | $15K | Buy |
+604
| New | +$15K | ﹤0.01% | 4499 |
|